Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body

International Journal of Pharmaceutics

Volumn 381, Issue 1, 2009, Pages 62-76

  Tamilvanan, Shunmugaperumal ^a  

^a Sankaralingam Bhuvaneswari College of Pharmacy   (India)

Author keywords

Generations of emulsion; Multifunctional; Nanosized emulsion; Opsonization; Pharmacopoeial and safety issues; Unique property

Indexed keywords

CALCIPOTRIOL; COCONUT OIL; CYCLOSPORIN A; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; DNA; EMLA; ETOMIDATE; FISH OIL; INFLUENZA VACCINE; INTRALIPID; LIPID EMULSION; LIPOFUNDIN; LIPOTALON; LIPOVENOES; MENATETRENONE; NANOCARRIER; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGAVEN; PACLITAXEL; POLIDOCANOL; POLYSORBATE 80; PROPOFOL; RITONAVIR; SORBITAN OLEATE; SOYBEAN OIL EMULSION; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER OIL CREAM;

CELL MEMBRANE PERMEABILITY; DRUG ABSORPTION; DRUG CONJUGATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; GENE THERAPY; HUMAN; IMMUNE SYSTEM; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

ANIMALS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIONS; GENE THERAPY; HUMANS; NANOSTRUCTURES; OPSONIN PROTEINS; ORGAN SPECIFICITY;

EID: 70349230769     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.08.001     Document Type: Review

References (153)

1. Abdulrazik M., Tamilvanan S., Khoury K., and Benita S. Ocular delivery of cyclosporin A. II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A. STP Pharma Sci. 11 (2001) 427-432
2. Adolph M. Lipid emulsions in parenteral nutrition. Ann. Nutr. Metab. 43 (1999) 1-13
3. Allison A.C., and Byars N.E. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95 (1986) 157-168
4. Alwayn I.P., Gura K., Nosé V., et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic liver disease. Pediatr. Res. 57 (2005) 445-452
5. Amselem S., and Friedman D. Submicron emulsions as drug carriers for topical administration. In: Benita S. (Ed). Submicron Emulsions in Drug Targeting and Delivery (1998), Harwood Academic Publishers, Amsterdam, The Netherlands 153-173
6. Araya J., Rodrigo R., Videla L.A., et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 106 (2004) 635-643
7. Arimoto I., Matsumoto C., Tanaka M., Okuhira K., Saito H., and Handa T. Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions. Lipids 33 (1998) 773-779
8. Attwood D. Microemulsions. In: Kreuter J. (Ed). Colloidal Drug Delivery Systems (1994), Marcel Dekker, New York 31-71
9. Battistella F.D., Widergren J.T., Anderson J.T., et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J. Trauma 43 (1997) 52-58
10. Becher P., and Schick M.J. Macroemulsions. In: Schick M.J. (Ed). Non-Ionic Surfactants, Surfactant Science Series vol. 23 (1987), Marcel Dekker, Basel 435-493
11. Benita S. Introduction and overview. In: Benita S. (Ed). Submicron Emulsion in Drug Targeting & Delivery (1998), Harwood Academic, The Netherlands 1-5
12. Bhadra D., Bhadra S., Jain P., and Jain N.K. Pegnology: a review of PEG-ylated systems. Pharmazie 57 (2002) 5-29
13. Bistrian B.R. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads lecture. J. Parenter. Enteral Nutr. 27 (2003) 168-175
14. Bloch A.S., and Shils M.E. Part VIII: appendices A-21: average values for triglycerides, fatty acids and cholesterol. In: Shils M.E., Shike M., Ross A.C., Caballero B., and Cousins R. (Eds). Modern Nutrition in Health and Disease. 10th ed. (2006), Lippincott, Williams & Wilkins, Baltimore, MD, USA
15. Calder P.C. Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc. Nutri. Soc. 68 (2009) 252-260
16. Calder P.C. Use of fish oil in parenteral nutrition: rationale and reality. Proc. Nutr. Soc. 65 (2006) 264-277
17. Calder P.C., and Burdge G.C. Fatty acids. In: Nicolaou A., and Kafatos G. (Eds). Bioactive Lipids (2004), The Oily Press, Bridgwater, Somerset 1-36
18. Calder P.C., Sherrington E.J., Askanazi J., et al. Inhibition of lymphocyte proliferation in vitro by two lipid emulsions with different fatty acid compositions. Clin. Nutr. 13 (1994) 69-74
19. Carter B.A., and Shulman R.J. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 4 (2007) 277-287
20. Carter B.A., Taylor O.A., Prendergast D.R., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr. Res. 62 (2007) 301-306
21. Ceglie A., Das K.P., and Lindman B. Microemulsion structure in four component systems for different surfactants. Colloid Surf. 28 (1987) 29-40
22. Chandra R.K., and Grace A. Goldsmith Award lecture. Trace element regulation of immunity and infection. J. Am. Coll. Nutr. 4 (1985) 5-16
23. Choi B.Y., Chung J.W., Park J.H., Kim K.H., Kim Y.I., Koh Y.H., Kwon J.W., Lee K.H., Choi H.J., Kim T.W., Kim Y.J., Chung H., Kwon I.C., and Jeong S.Y. Gene delivery to the rat liver using cationic lipid emulsion/DNA complex: comparison between intra-arterial, intraportal and intravenous administration. Korean J. Radiol. 3 (2002) 194-198
24. Chapter 797. Pharmaceutical Compounding: Sterile Preparations: Physical Tests: United States Pharmacopeia 29/National Formulary 24 (2006), United States Pharmacopeia Convention, Inc., Rockville, MD pp. 2735-2751
25. Clayton P.T., Whitfield P., and Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14 (1998) 158-164
26. Davis S.S. Emulsions systems for the delivery of drugs by the parenteral route. In: Bundgaard H., Bagger Hansen A., and Kofod H. (Eds). Optimization of Drug Delivery (1982), Munksgaard, Copenhagen 333-346
27. Davis S.S., and Hansrani P. The influence of emulsifying agents on the phagocytosis of lipid emulsions by macrophages. Int. J. Pharm. 23 (1985) 69-77
28. Davis S.S., Illum L., Washington C., and Harper G. Studies on the interaction of charge-reversed emulsions with the reticuloendothelial system. Int. J. Pharm. 82 (1992) 99-105
29. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
30. Deckelbaum R.J., Hamilton J.A., Moser A., Bengtsson-Olivecrona G., Butbul E., Carpentier Y.A., Gutman A., and Olivecrona T. Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry 29 (1990) 1136-1142
31. Decker D.E., Vroegop S.M., Goodman T.G., Peterson T., and Buxser S.E. Kinetics and thermodynamics of emulsion delivery of lipophilic antioxidants to cells in culture. Chem. Phys. Lipids 76 (1995) 7-25
32. ® on some immunological parameters and leukocyte functions in patients with esophageal and gastric cancer. Clin. Nutr. 4 (1985) 229-234
33. Driscoll D.F. Lipid injectable emulsions: pharmacopoeial and safety issues. Pharm. Res. 23 (2006) 1959-1969
34. Driscoll D.F. Examination of selection of light-scattering and light-obscuration acceptance criteria for lipid injectable emulsions. Pharm. Forum 30 (2004) 2244-2253
35. Driscoll D.F. The significance of particle-sizing measurements in the safe use of intravenous fat emulsions. J. Disp. Sci. Technol. 23 (2002) 679-687
36. Driscoll D.F. Physicochemical assessment of total nutrient admixture stability and safety: quantifying the risk [editorial]. Nutrition 12 (1997) 166-167
37. Driscoll D.F., Ling P.R., Quist W.C., and Bistrian B.R. Pathological consequences from the infusion of unstable lipid emulsion admixtures in guinea pigs. Clin. Nutr. 24 (2005) 105-113
38. Driscoll D.F., Ling P.R., and Bistrian B.R. Hepatic indicators of oxidative stress following a 72-h infusion of an unstable all-in-one (AIO) in rats. Clin. Nutr. 23 (2004) 857
39. Driscoll D.F., Ling P.R., Quist W.C., and Bistrian B.R. Hepatic indicators of inflammation following the infusion of pharmaceutically unstable all-in-one mixtures in rats. Clin. Nutr. 22 (2003) S16-S17 O-59
40. Driscoll D.F., Etzler F., Barber T.A., Nehne J., Niemann W., and Bistrian B.R. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int. J. Pharm. 219 (2001) 21-37
41. Driscoll D.F., Adolph M., and Bistrian B.R. Lipid emulsions in parenteral nutrition. In: Rombeau J.L., and Rolandelli R.H. (Eds). Clinical Nutrition: Parenteral Nutrition. 3rd ed. (2001), W.B. Saunders and Co., Philadelphia, PA 35-59
42. Edgren B., and Wrtelind A. The theoretical background of the intravenous nutrition with fat emulsions. Nutr. Dieta Eur. Rev. Nutr. Diet. 13 (1963) 364-386
43. El-Aasser M.S., and Sudol E.D. Miniemulsions. JCT Res. 1 (2004) 21-31
44. Elbaz E., Zeevi A., Klang S., and Benita S. Positively charged submicron emulsions-a new type of colloidal drug carrier. Int. J. Pharm. 96 (1993) R1-R6
45. Er Ãfnofas I., Csoka I., Csany E., Orosz K., and Makai M. Proceedings of 2nd World Meeting APGI/APV. Paris (1998) 805-806
46. Farah R.A., Clinchy B., Herrera L., and Vitetta E.S. The development of monoclonal antibodies for the therapy of cancer. Crit. Rev. Eukaryot. Gene Expr. 8 (1998) 321-356
47. Floyd A.G. Top ten considerations in the development of parenteral emulsions. Pharm. Sci. Technol. Today 2 (1999) 134-143
48. Fukushima S., Kishimoto S., Takeuchi Y., and Fukushima M. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. Adv. Drug Deliv. Rev. 45 (2000) 65-75
49. Furukawa K., Yamamori H., Takagi K., et al. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 18 (2002) 235-240
50. Gallarate M., Carlotti M.E., Trotta M., and Bovo S. On the stability of ascorbic acid in emulsified systems for topical and cosmetic use. Int. J. Pharm. 188 (1999) 233-241
51. Gogos C.A., Kalfarentzos F.E., and Zoumbos N.C. Effect of different types of total parenteral nutrition on T-lymphocyte subpopulations and NK cells. Am. J. Clin. Nutr. 51 (1990) 119-122
52. Goldstein D., Nassar T., Lambert G., Kadouche J., and Benita S. The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. J. Control. Release 108 (2005) 418-432
53. Goldstein D., Gofrit O., Nyska A., and Benita S. Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer. Cancer Res. 67 (2007) 269-275
54. Grimminger F., Wahn H., Mayer K., Kiss L., Walmrath D., and Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am. J. Respir. Crit. Care Med. 155 (1997) 513-519
55. Grolier P., Azais-Braesco V., Zelmire L., and Fessi H. Incorporation of carotenoids in aqueous systems: uptake by cultured rat hepatocytes. Biochim. Biophys. Acta 1111 (1992) 135-138
56. Gura K.M., Duggan C.P., Collier S.B., et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 118 (2006). http://www.pediatrics.org/cgi/content/full/118/1/e197 Available at: www.pediatrics.org/cgi/content/full/118/1/e197
57. Gura K.M., Lee S., Valim C., Zhou J., Kim S., Modi B.P., Arsenault D.A., Strijbosch R.A.M., Lopes S., Duggan C., and Puder M. Safety and efficacy of a fish oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 121 (2008) e678-e686. http://www.pediatrics.org/cgi/content/full/121/3/e678 Available at: http://www.pediatrics.org/cgi/content/full/121/3/e678
58. Gurr M.I., Harwood J.L., and Frayn K.N. Lipid Biochemistry: An Introduction. 5th ed. (2002), Wiley-Blackwell, Oxford
59. Gursoy R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004) 173-182
60. Hallberg D., Schuberth O., and Wretlind A. Experimental and clinical studies with fat emulsion for intravenous nutrition. Nutr. Dieta Eur. Rev. Nutr. Diet. 8 (1966) 245-281
61. Halliwell B., and Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am. J. Clin. Nutr. 57 Suppl. (1993) 715-724
62. Harbige L.S. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc. Nutr. Soc. 57 (1998) 555-562
63. Harris J.M., Martin N.E., and Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin. Pharmacokinet. 40 (2001) 539-551
64. Hasselmann M., and Reimund J.M. Lipids in the nutritional support of critically ill patients. Curr. Opin. Crit. Care 10 (2004) 449-455
65. Hedeman H., Brøndsted H., Müllertz A., and Frokjaer S. Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vivo fate. Pharm. Res. 13 (1996) 725-728
66. Hino T., Kawashima Y., and Shimabayashi S. Basic study for stabilization of w/o/w emulsion and its application to transcatheter arterial embolization therapy. Adv. Drug Deliv. Rev. 45 (2000) 27-45
67. Holman R.T., Johnson S.B., and Hatch T.F. A case of human linolenic acid deficiency involving neurological abnormalities. Am. J. Clin. Nutr. 35 (1982) 617-623
68. Horrocks L.A., and Yoe Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40 (1999) 211-225
69. Illum L., West P., Washington C., and Davis S.S. The effect of stabilising agents on the organ distribution of lipid emulsions. Int. J. Pharm. 54 (1989) 41-49
70. Iwamoto K., Kato T., Kawahara M., Koyama N., Watanabe S., Miyake Y., and Sunamoto J. Polysaccharide-coated oil droplets in oil-in-water emulsions as targetable carriers for lipophilic drugs. J. Pharm. Sci. 80 (1991) 219-224
71. Kabalnov A. Thermodynamic and theoretical aspects of emulsions and their stability. Curr. Opin. Colloid Interface Sci. 3 (1998) 270-275
72. Kim T.W., Chung H., Kwon I.C., Sung H.C., and Jeong S.Y. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents. Pharm. Res. 18 (2001) 54-60
73. Kim Y.J., Kim T.W., Chung H., Kwon I.C., Sung H.C., and Jeong S.Y. Counterion effects on transfection activity of cationic lipid emulsion. Biotechnol. Bioprocess. Eng. 6 (2001) 279-283
74. Kim Y.J., Kim T.W., Chung H., Kwon I.C., Sung H.C., and Jeong S.Y. The effects of serum on the stability and the transfection activity of the cationic lipid emulsion with various oils. Int. J. Pharm. 252 (2003) 241-252
75. Klang S., Abdulrazik M., and Benita S. Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution. Pharm. Dev. Technol. 5 (2000) 521-532
76. Klang S.H., and Benita S. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration. In: Benita S. (Ed). Submicron Emulsion in Drug Targeting & Delivery (1998), Harwood Academic, The Netherlands 119-152
77. Klang S.H., Parnas M., and Benita S. Emulsions as drug carriers-possibilities, limitations, and future perspectives. In: Muller R.H., Benita S., and Bohm H.L. (Eds). Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs (1998), Medpharm, Stuttgart 31-65
78. Klein S., and Miles J.M. Metabolic effects of long-chain and medium chain triglycerides in humans. J. Parenter. Enteral Nutr. 18 (1994) 396-397
79. Koch T., and Heller A.R. Auswirkungen einer parenteralen ernahrung mit n-3-fettsauren auf das therapieergebnis-eine multizentrische analyse bei 661 patienten (Effects of parenteral nutrition with n-3-fatty acids on the result of therapy-a multicentre analysis with 661 patients). Akt. Ernahrungs 30 (2005) 15-22
80. Koletzko B. Intravenous lipid infusion in infancy-physiological aspects and clinical relevance. Clin. Nutr. 21 Suppl. (2002) 53-65
81. Koning G.A., and Krijger G.C. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anti-Cancer Agents Med. Chem. 7 (2007) 425-440
82. Krafft M.P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv. Drug Deliv. Rev. 47 (2001) 209-228
83. Kurihara A., Shibayama Y., Mizota A., Yasuna A., Ikeda M., Sasagawa K., Kobayashi T., and Hisaoka M. Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution. Biopharm. Drug Dispos. 17 (1996) 331-342
84. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Dietary n-3 fatty acids in the prevention of cardiac arrhythmias. Curr. Opin. Clin. Nutr. Metab. Care 1 (1998) 225-228
85. Lee J.H., Lee H.B., and Andrade J.D. Blood compatibility of polyethylene oxide surfaces. Prog. Polym. Sci. 20 (1995) 1043-1079
86. Lee I.H., Park Y.T., Ron K., Chung H., Kwon I.C., and Jeong S.Y. Stable paclitaxel formulations in oily contrast medium. J. Control. Release 102 (2005) 415-425
87. Lehner F., Demmelmair H., Röschinger W., Decsi T., Szász M., Adamovich K., Arnecke R., and Koletzko1 B. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J. Lipid Res. 47 (2006) 404-411
88. Lekka M.E., Liokatis S., Nathanail C., Galani V., and Nakos G. The impact of intravenous fat emulsion administration in acute lung injury. Am. Rev. Respir. Crit. Care Med. 169 (2004) 638-644
89. Lenssen P., Bruemmer B.A., Bowden R.A., et al. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am. J. Clin. Nutr. 67 (1998) 927-933
90. Levy M.Y., Benita S., and Baszkin A. Interactions of a non-ionic surfactant with mixed phospholipid-oleic acid monolayers. Studies under dynamic conditions. Colloids Surf. 59 (1991) 225-241
91. Lin S.Y., Wu W.H., and Lui W.Y. In vitro release, pharmacokinetic and tissue distribution studies of doxorubicin hydrochloride (Adriamycin HCl) encapsulated in lipiodolized w/o emulsions and w/o/w multiple emulsions. Pharmazie 47 (1992) 439-443
92. Liu F., and Liu D. Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs. Pharm. Res. 12 (1995) 1060-1064
93. Lowe K.C. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev. 13 (1999) 171-184
94. Lundberg B.B., Griffiths G., and Hansen H.J. Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions. J. Pharm. Pharmacol. 51 (1999) 1099-1105
95. Lundberg B.B., Mortimer B.C., and Redgrave T.G. Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time. Int. J. Pharm. 134 (1996) 119-127
96. Lundberg B.B., Risovic V., Ramaswamy M., and Wasan K.M. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J. Control. Release 86 (2003) 93-100
97. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
98. McCowen K.C., and Bistrian B.R. Essential fatty acids and their derivatives. Curr. Opin. Gastroenterol. 21 (2005) 207-215
99. 13C: a comparison of oxidation after oral or parenteral administration in humans. J. Nutr. 121 (1991) 31-36
100. Mizushima Y., Hoshi K., Aihara H., and Kurachi M. Inhibition of bronchoconstriction by aerosol of a lipid emulsion containing prostaglandin E1. J. Pharm. Pharmacol. 35 (1983) 397
101. Monson J.R.T., Sedman P.C., Ramsden C.W., et al. Total parenteral nutrition adversely influences tumour-directed cellular cytotoxic responses in patients with gastrointestinal cancer. Eur. J. Surg. Oncol. 14 (1988) 435-443
102. Myers, K.R., Truchot, A.T., 1990. U.S. Patent 4,912,094 (March 27).
103. Nakajima H. Microemulsions in cosmetics. In: Solans C., and Kunieda H. (Eds). Industrial Applications of Microemulsions (1997), Marcel Dekker, New York 175-197
104. O'Connor Hall D.L.R., Adamkin D., Auestad N., Castillo M., Connor W.E., Connor S.L., Fitzgerald K., Groh-Wargo S., Hartmann E., et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 108 (2001) 359-371
105. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect. Control Hosp. Epidemiol. 23 (2002) 759-769
106. Ott G., Singh M., Kazzaz J., Briones M., Soenawan E., Ugozzoli M., and O' Hagan D.T. A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J. Control. Release 79 (2002) 1-5
107. Porter C.J., Charman S.A., and Charman W.N. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J. Pharm. Sci. 85 (1996) 351-356
108. Rensen P.C.N., Van Dijk M.C.M., Havenaar E.C., Bijsterbosch M.K., Kruijt J.K., and Van Berkel T.J.C. Selective liver targeting of antivirals by recombinant chylomicrons-a new therapeutic approach to hepatitis. Nat. Med. 1 (1995) 221-225
109. Reiter P.D. Sterility of intravenous fat emulsion in plastic syringes. Am. J. Health Syst. Pharm. 59 (2002) 1857-1859
110. Ribi, E.E., 1984. U.S. Patent 4,436,727 (March 13).
111. Ribi, E., Schwartzman, S.M., Cantrell, J.L., 1984. U.S. Patent 4,436,728 (March 13).
112. Rojanasakul Y., and Robinson J.R. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int. J. Pharm. 55 (1989) 237-246
113. Rubin M., Harell D., Naor N., Moser A., Wielunsky E., Merlob P., and Lichtenberg D. Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. J. Parenter. Enteral Nutr. 15 (1991) 642-646
114. Rubin M., Moser A., Naor N., Merloh P., Pakula R., and Sirota L. Effect of three intravenously administered fat emulsions containing different concentrations of fatty acids on the plasma fatty acid composition of premature infants. J. Pediatr. 125 (1994) 596-602
115. Saba T.M. Physiology and physiopathology of the reticuloendothelial system. Arch. Intern. Med. 126 (1970) 1031-1052
116. Sacks G.S., and Driscoll D.F. Does lipid hang time make a difference? Time is of the essence. Nutr. Clin. Pract. 17 (2002) 284-290
117. Sakaeda T., and Hirano K. O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug. J. Drug Target. 3 (1995) 221-230
118. Sakaeda T., Takahashi K., Nishihara Y., and Hirano K. O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II. Biol. Pharm. Bull. 17 (1994) 1490-1495
119. Salem N., Wegher B., Mena P., and Uauy R. Arachidonic and docohexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 49-54
120. SanGiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., and Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105 (2000) 1292-1298
121. Sedman P.C., Somers S.S., Ramsden C.W., et al. Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br. J. Surg. 78 (1991) 1396-1399
122. Shils M.E. Parenteral nutrition. In: Shils M.E., Olson J.A., Shike M.E., and Ross O. (Eds). Modern Nutrition in Health and Disease. 9th ed. (1998), Williams & Wilkins, Baltimore, PA
123. Sofou S. Surface-active liposomes for targeted cancer therapy. Nanomedicine 2 (2007) 711-724
124. Solans C., Izquierdo P., Nolla J., Azemar N., and Garcia-Celma M.J. Nanoemulsions. Curr. Opin. Colloid Interface Sci. 10 (2005) 102-110
125. Song Y.K., Liu D.X., Maruyama K., and Takizawa T. Antibody mediated lung targeting of long-circulating emulsions. PDA J. Pharm. Sci. Technol. 50 (1996) 372-377
126. Spahn D.R. Current status of artificial oxygen carriers. Adv. Drug Deliv. Rev. 40 (2000) 143-151
127. Spielmann D., Bracco U., Traitler H., Crozier G., Holman R.T., Ward M., and Cotter R. Alternative lipids to usual omega 6 PUFAS: gamma-linolenic acid, alpha linolenic acid, stearidonic acid, EPA etc. J. Parenter. Enteral Nutr. 12 Suppl. (1988) 111-123
128. Sprecher H. The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 79-83
129. Stefan A., Palazzo G., Ceglie A., Panzavolta E., and Hochkoeppler A. Water-in-oil macroemulsions sustain long-term viability of microbial cells in organic solvents. Biotechnol. Bioeng. 81 (2003) 323-328
130. 13C-labelled linoleic acid in newborn infants during the first week of life. Pediatr. Res. 45 (1999) 669-673
131. Tadros T.F., Izquierdo P., Esquena J., and Solans C. Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. 108-109 (2004) 303-318
132. Takino T., Konishi K., Takakura Y., and Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol. Pharm. Bull. 17 (1994) 121-125
133. Takino T., Koreeda N., Nomura T., Sakaeda T., Yamashita F., Takakura Y., and Hashida M. Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems. Biol. Pharm. Bull. 21 (1998) 492-497
134. Takino T., Nakajima C., Takakura Y., Sezaki H., and Hashida M. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J. Drug Target. 1 (1993) 117-124
135. Tamilvanan S. Oil-in-water nanosized emulsions: medical applications. In: Gad S.C. (Ed). Pharmaceutical Manufacturing Handbook (2008), John Wiley & Sons Publishers, NJ, USA 1329-1368 (Chap. 7.4)
136. Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog. Lipid Res. 43 (2004) 489-533
137. Tamilvanan S., and Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm. 58 (2004) 357-368
138. Teixeira H., Dubernet C., Puisieux F., Benita S., and Couvreur P. Submicron cationic emulsions as a new delivery system for oligonucleotides. Pharm. Res. 16 (1999) 30-36
139. Tirucherai G.S., Pezron I., and Mitra A.K. Novel approaches to nasal delivery of peptides and proteins. STP Pharm. Sci. 12 (2002) 3-12
140. Torchilin V.P. Nanocarriers. Pharm. Res. 24 (2007) 2333-2334
141. In: Torchilin V.P. (Ed). Nanoparticulates as Pharmaceutical Carriers (2006), Imperial College Press, London, UK
142. Ulrich H., McCarthy Pastores S., Katz D.P., et al. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 12 (1996) 231-238
143. Ueda K., Ishida M., Inoue T., Fujimoto M., Kawahara Y., Sakaeda T., and Iwakawa S. Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsions in rats. J. Drug Target. 9 (2001) 353-360
144. Ueda K., Yamazaki Y., Noto H., Teshima Y., Yamashita C., Sakaeda T., and Iwakawa S. Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats. J. Drug Target. 11 (2003) 37-43
145. Van Aerde J.E., Duerksen D.R., Gramlich L., et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr. Res. 45 (1999) 202-208
146. Wanten G.J., and Calder P.C. Immune modulation by parenteral lipid emulsions. Am. J. Clin. Nutr. 85 (2007) 1171-1184
147. Wheeler J.J., Wong K.F., Ansell S.M., Masin D., and Bally M.B. Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol. J. Pharm. Sci. 83 (1994) 1558-1564
148. Wretlind A. Complete intravenous nutrition. Theoretical and experimental background. Nutr. Metab. (Lond.) 14 Suppl. (1972) 1-57
149. Wretlind A. Parenteral nutrition. Nutr. Rev. 39 (1981) 257-265
150. Yang S.C., and Benita S. Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev. Res. 50 (2000) 476-486
151. Yamaguchi T., Nishizaki K., Itai S., Hayashi H., and Ohshima H. Physicochemical characterization of parenteral lipid emulsion: influence of cosurfactants on flocculation and coalescence. Pharm. Res. 12 (1995) 1273-1278
152. Yi S.W., Yune Y., Kim T.W., Chung H., Choi Y.W., Kwon I.C., Lee E.B., and Jeong S.Y. A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharm. Res. 17 (2000) 314-320
153. Zaman N., Tam Y.K., Jewell L.D., and Coutts R.T. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm. Drug Dispos. 18 (1997) 803-819